ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in early stage Gallbladder Cancer
Prajish Iyer, Shailesh V Shrikhande, Malika Ranjan, Asim Joshi, Ratnam Prasad, Nilesh Gardi, Rahul Thorat, Sameer Salunkhe, Bhasker Dharavath, Bikram Sahoo, Pratik Chandrani, Hitesh Kore, Bhabani Mohanty, Vikram Chaudhari, Anuradha Choughule, Dhananjay Kawle, Pradip Chaudhari, Arvind Ingle, Shripad Banavali, Mukta R Ramadwar, Kumar Prabhash, Savio George Barreto, Shilpee Dutt, Amit Dutt
bioRxiv 290486; doi: https://doi.org/10.1101/290486
